U.S. flag

An official website of the United States government

NM_000410.4(HFE):c.193A>T (p.Ser65Cys) AND not specified

Germline classification:
Uncertain significance (3 submissions)
Last evaluated:
Jul 31, 2024
Review status:
2 stars out of maximum of 4 stars
criteria provided, multiple submitters, no conflicts
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001328435.12

Allele description [Variation Report for NM_000410.4(HFE):c.193A>T (p.Ser65Cys)]

NM_000410.4(HFE):c.193A>T (p.Ser65Cys)

Genes:
HFE-AS1:HFE antisense RNA 1 [Gene - HGNC]
HFE:homeostatic iron regulator [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
6p22.2
Genomic location:
Preferred name:
NM_000410.4(HFE):c.193A>T (p.Ser65Cys)
HGVS:
  • NC_000006.12:g.26090957A>T
  • NG_008720.2:g.8677A>T
  • NM_000410.4:c.193A>TMANE SELECT
  • NM_001300749.3:c.193A>T
  • NM_001384164.1:c.193A>T
  • NM_001406751.1:c.193A>T
  • NM_139003.3:c.193A>T
  • NM_139004.3:c.193A>T
  • NM_139006.3:c.193A>T
  • NM_139007.3:c.77-357A>T
  • NM_139008.3:c.77-357A>T
  • NM_139009.3:c.124A>T
  • NM_139010.3:c.77-1728A>T
  • NM_139011.3:c.77-2162A>T
  • NP_000401.1:p.Ser65Cys
  • NP_000401.1:p.Ser65Cys
  • NP_000401.1:p.Ser65Cys
  • NP_001287678.1:p.Ser65Cys
  • NP_001287678.1:p.Ser65Cys
  • NP_001371093.1:p.Ser65Cys
  • NP_001393680.1:p.Ser65Cys
  • NP_620572.1:p.Ser65Cys
  • NP_620573.1:p.Ser65Cys
  • NP_620575.1:p.Ser65Cys
  • NP_620578.1:p.Ser42Cys
  • LRG_748t1:c.193A>T
  • LRG_748:g.8677A>T
  • LRG_748p1:p.Ser65Cys
  • NC_000006.11:g.26091185A>T
  • NM_000410.3:c.193A>T
  • NM_001300749.2:c.193A>T
  • NR_144383.1:n.78T>A
  • Q30201:p.Ser65Cys
Protein change:
S42C; SER65CYS
Links:
Genetic Testing Registry (GTR): GTR000321635; UniProtKB: Q30201#VAR_004397; OMIM: 613609.0003; dbSNP: rs1800730
NCBI 1000 Genomes Browser:
rs1800730
Molecular consequence:
  • NM_139007.3:c.77-357A>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_139008.3:c.77-357A>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_139010.3:c.77-1728A>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_139011.3:c.77-2162A>T - intron variant - [Sequence Ontology: SO:0001627]
  • NM_000410.4:c.193A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001300749.3:c.193A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001384164.1:c.193A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001406751.1:c.193A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139003.3:c.193A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139004.3:c.193A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139006.3:c.193A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_139009.3:c.124A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NR_144383.1:n.78T>A - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001519564Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Uncertain significance
(Feb 26, 2021)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Citation Link,

SCV002517178Mendelics
criteria provided, single submitter

(Mendelics Assertion Criteria 2019)
Uncertain significance
(May 4, 2022)
germlineclinical testing

Citation Link,

SCV004242530Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain significance
(Jul 31, 2024)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.

Pedersen P, Milman N.

Ann Hematol. 2009 Aug;88(8):775-84. doi: 10.1007/s00277-008-0679-1. Epub 2009 Jan 22.

PubMed [citation]
PMID:
19159930

Molecular epidemiology of HFE gene polymorphic variants (C282Y, H63D and S65C) in the population of EspĂ­rito Santo, Brazil.

Alves LN, Santos EV, Stur E, Silva Conforti AM, Louro ID.

Genet Mol Res. 2016 Apr 27;15(2). doi: 10.4238/gmr.15028189.

PubMed [citation]
PMID:
27173269
See all PubMed Citations (8)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001519564.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

Variant summary: HFE c.193A>T (p.Ser65Cys) results in a non-conservative amino acid change located in the MHC class I-like antigen recognition-like domain (IPR011161) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.01 in 251490 control chromosomes in the gnomAD database, including 24 homozygotes. This frequency is not significantly higher than expected for a pathogenic variant in HFE causing Hemochromatosis Type 1 (0.01 vs 0.046), allowing no conclusion about variant significance. c.193A>T has been reported in association with Hemochromatosis Type 1 in at least one published study, in which the variant was enriched in individuals affected with Hemochromatosis who did not have two alleles with some combination of the more common disease mutations p.C282Y and p.H63D (e.g. Mura_1999). This data suggested a possibly pathogenic role for the p.S65C variant. However, the variant has also been found in compound heterozygosity with these other disease variants in controls, and additional studies did not find association of the variant with the Hemochromatosis phenotype (e.g. Arya_1999, Oliveira_2009, Pedersen_2009). At least one publication reported an association for the variant with mild to moderate changes in serum ferritin and/or transferrin levels in indivduals who were compound heterozygotes for this variant and one of the common disease variants, however these individuals did not have clinical symptoms of iron load typically found in patients diagnosed with Hemochromatosis Type 1 (e.g. Holmstrom_2002). These reports do not provide unequivocal conclusions about association of the variant with Hemochromatosis Type 1. To our knowledge, no conclusive experimental evidence demonstrating an impact on protein function has been reported. Five ClinVar submitters (evaluation after 2014) have cited the variant as uncertain significance (n=4) and likely pathogenic (n=1). Based on the majority concordance in its classification among peers in the field supported by the evidence outlined above, the variant was classified as uncertain significance until additional information becomes available.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Mendelics, SCV002517178.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

From Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital, SCV004242530.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Sep 16, 2024